Sfoglia per RIVISTA
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Collezione AO Ordine Mauriziano
Items : 1
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. in International journal of rheumatic diseases / Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.
2018
AO Ordine Mauriziano
AOU Città della Salute di Torino
Favalli EG; Sinigaglia L; Becciolini A; Grosso V; Gorla R; Bazzani C; Atzeni F; Sarzi Puttini PC; Fusaro E; Pellerito R; Caporali R;